325 related articles for article (PubMed ID: 7692611)
21. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
Collen D
Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
[No Abstract] [Full Text] [Related]
22. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
[No Abstract] [Full Text] [Related]
23. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
24. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
25. Change of lipoprotein(a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
Nagai T; Tomizawa T; Mori M
Diabetes Care; 1993 Oct; 16(10):1411-2. PubMed ID: 8269808
[No Abstract] [Full Text] [Related]
26. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
27. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
Suharti C; van Gorp EC; Setiati TE; Dolmans WM; Djokomoeljanto RJ; Hack CE; ten CH; van der Meer JW
Thromb Haemost; 2002 Jan; 87(1):42-6. PubMed ID: 11858187
[TBL] [Abstract][Full Text] [Related]
28. [Prevention and early diagnosis of disseminated intravascular coagulation].
Matsuda T
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1375-82. PubMed ID: 8245630
[No Abstract] [Full Text] [Related]
29. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
30. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
Booth NA; Bennett B
Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
[TBL] [Abstract][Full Text] [Related]
31. [Laboratory tests of coagulation and fibrinolysis for the diagnosis of rheumatoid arthritis].
Koshihara K; Fukutake K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():358-61. PubMed ID: 15799378
[No Abstract] [Full Text] [Related]
32. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
Velasco F; Torres A; Andres P; Martinez F; Gomez P
Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
[TBL] [Abstract][Full Text] [Related]
33. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
34. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
Itoh N
Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
[No Abstract] [Full Text] [Related]
35. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
36. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
Kanamori N; Koiwa F; Uda S
Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
[No Abstract] [Full Text] [Related]
37. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
[TBL] [Abstract][Full Text] [Related]
38. [Correlation between coagulation and fibrinolysis in patient with cerebrovascular accident at acute stage].
Takemoto Y; Fukuda A; Tanaka S; Tanabe J; Ikeda H; Fujii C; Kohama A
No To Shinkei; 1982 Oct; 34(10):1007-10. PubMed ID: 7150448
[TBL] [Abstract][Full Text] [Related]
39. [Plasmin-alpha2 plasmin inhibitor complex (PIC)].
Yoshikawa Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():711-3. PubMed ID: 15658431
[No Abstract] [Full Text] [Related]
40. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
